Obexelimab for the Treatment of IgG4-Related Disease
Original Article
E. Della-Torre, M.C. Baker, W. Zhang, C.A. Perugino, G. Katz, Y. Tanaka, A. Khosroshahi, A. Kleger, N. Schleinitz, F. Martinez-Valle, H. Schulze-Koops, S. Nakayamada, V. Rebours, K. Okazaki, L. Dong, M. Carruthers, L.Y. Chen, L. Frulloni, A. Meysami, H. Takahashi, M. Kawano, Y. Liu, T. Saeki, M. Ebbo, T. Alexander, A.G. García, O. Karadag, M. Maślińska, S.M. Quinn, A. Poma, A. Wells, T.J. Greene, J.H. Stone, and E.L. Culver
N Engl J Med 2026;395:1273-1284
Course summary
Available credit:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course opens:
09/30/2026
Course expires:
10/01/2028
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Please sign in or create an account to take the course.

Facebook
X
LinkedIn
Forward